Jiangsu Nhwa Pharmaceutical Hits Day High with 4.37% Intraday Surge

Jiangsu Nhwa Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 4.37% on July 1, 2026. The stock reached an intraday high of CNY 19.58, marking a notable performance compared to the China Shanghai Composite, which only increased by 0.44% on the same day. Over the past week, Jiangsu Nhwa has demonstrated a 2.89% gain, while its one-month performance reflects a decline of 5.28%. In the longer term, the stock has faced challenges, with a year-to-date performance down by 18.9% and a three-year performance showing a decrease of 36.52%. Despite these trends, the company maintains a market capitalization of CNY 17,104 million and a price-to-earnings ratio of 16.00. The pharmaceutical and biotechnology sector continues to be competitive, and Jiangsu Nhwa's current dividend yield stands at 2.05%. While the company has experienced fluctuations in its financial metrics, including a return on equity of 12.80%, it remains a significant player in its industry.